Janus Henderson Biotech Innovation Master Fund Ltd, 10% Owner at ARCA biopharma, Inc. (ABIO), bought 761,454 shares at $3.55 ($2.7M) on 2024-07-03, disclosed to the SEC on 2024-07-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.55 | 166,042 | $589K | 22.2% |
| 2 | $3.55 | 166,042 | $589K | 22.2% |
| 3 | $3.41 | 5,000 | $17K | 0.6% |
| 4 | $3.43 | 23,326 | $80K | 3.0% |
| 5 | $3.43 | 23,326 | $80K | 3.0% |
| 6 | $3.41 | 29,892 |
| $102K |
| 3.8% |
| 7 | $3.41 | 29,892 | $102K | 3.8% |
| 8 | $3.54 | 17,600 | $62K | 2.3% |
| 9 | $3.43 | 16,917 | $58K | 2.2% |
| 10 | $3.43 | 16,917 | $58K | 2.2% |
| 11 | $3.46 | 21,963 | $76K | 2.9% |
| 12 | $3.46 | 21,963 | $76K | 2.9% |
| 13 | $3.46 | 33,500 | $116K | 4.4% |
| 14 | $3.45 | 94,537 | $326K | 12.3% |
| 15 | $3.45 | 94,537 | $326K | 12.3% |
| Total | $3.49 avg | 761,454 | $2.7M | 100% |